GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NIOX Group PLC (LSE:NIOX) » Definitions » Price-to-Funds-From-Operations

NIOX Group (LSE:NIOX) Price-to-Funds-From-Operations : (As of Dec. 13, 2024)


View and export this data going back to 2014. Start your Free Trial

What is NIOX Group Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


NIOX Group Business Description

Traded in Other Exchanges
Address
Edmund Halley Road, Hayakawa Building, The Oxford Science Park, Oxford, GBR, OX4 4GB
NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world.